Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 13, 2019 16:15 ET | Source: T2 Biosystems, Inc.

T2 Biosystems Reports Granting of Inducement Awards

LEXINGTON, Mass., Dec. 13, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet...
November 20, 2019 07:30 ET | Source: T2 Biosystems, Inc.

T2 Biosystems Announces Granting of CE-Mark for T2Resistance™ Panel

LEXINGTON, Mass., Nov. 20, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet...
November 15, 2019 07:30 ET | Source: T2 Biosystems, Inc.

T2 Biosystems to Present at the 13th Annual Canaccord Genuity Medical Technology & Diagnostics Forum

LEXINGTON, Mass., Nov. 15, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company,”“T2,” or “T2 Biosystems”), a leader in the development and commercialization of innovative...
November 12, 2019 07:30 ET | Source: T2 Biosystems, Inc.

T2 Biosystems Reports Third Quarter 2019 Financial Highlights and Provides Corporate Update

LEXINGTON, Mass., Nov. 12, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company,”“T2,” or “T2 Biosystems”), a leader in the development and commercialization of innovative...
November 08, 2019 16:15 ET | Source: T2 Biosystems, Inc.

T2 Biosystems Reports Granting of Inducement Awards

LEXINGTON, Mass., Nov. 08, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet...
November 07, 2019 07:30 ET | Source: T2 Biosystems, Inc.

T2 Biosystems to Share Early Data at the World Anti-Microbial Resistance Congress (November 7-8, 2019)

LEXINGTON, Mass., Nov. 07, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development of innovative diagnostic products for critical unmet needs in healthcare, announced...
October 31, 2019 16:15 ET | Source: T2 Biosystems, Inc.

T2 Biosystems Announces 2019 Third Quarter Financial and Operational Results Release and Conference Call Date

LEXINGTON, Mass., Oct. 31, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development of innovative diagnostic products for critical unmet needs in healthcare, announced...
October 11, 2019 07:30 ET | Source: T2 Biosystems, Inc.

T2 Biosystems Reports Granting of Inducement Awards

LEXINGTON, Mass., Oct. 11, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet...
October 02, 2019 07:30 ET | Source: T2 Biosystems, Inc.

T2 Biosystems to Showcase Latest Innovations at IDWeek 2019

LEXINGTON, Mass., Oct. 02, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development of innovative diagnostic products for critical unmet needs in healthcare, announced...
September 30, 2019 07:30 ET | Source: T2 Biosystems, Inc.

T2 Biosystems’ T2Resistance™ Panel is Now Available as a Research Use Only (RUO) Test in the U.S.

LEXINGTON, Mass., Sept. 30, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development of innovative diagnostic products for critical unmet needs in healthcare,...